Filing Flows › Stryker (SYK) › How it makes money
How Stryker (SYK) makes money
Stryker (SYK) made $6.5B of revenue in the third quarter 2026 (Q3 2026), +8% from a year earlier. MedSurg and Neurotechnology: brought in $3.7B (56%); Orthopaedics: brought in $2.9B (44%). Of every dollar of revenue, 65¢ was left as gross profit, 16¢ was left as operating profit, 12¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| MedSurg and Neurotechnology: | $3.7B | 56.2% | +1% | +9% |
| Orthopaedics: | $2.9B | 43.8% | -4% | +6% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $6.5B | 100.0% |
| Cost of revenue | $2.3B | 34.8% |
| Gross profit | $4.2B | 65.2% |
| Operating expenses | $3.2B | 49.3% |
| Operating profit | $1.0B | 15.9% |
| Income tax | $244M | 3.7% |
| Net earnings | $753M | 11.5% |
| Operating cash flow | $1.5B | 22.4% |
| Free cash flow | $1.2B | 18.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $6.5B | +8% |
| Q2 2026 | $6.6B | +9% |
| Q1 2026 | $6.0B | +3% |
| Q4 2025 | $7.2B | +11% |
| Q3 2025 | $6.1B | +10% |
| Q2 2025 | $6.0B | +11% |
| Q1 2025 | $5.9B | +12% |
From Stryker's 10-Q filed Oct 30, 2026 (on EDGAR).
Questions
How does Stryker make money?
Stryker (SYK) made $6.5B of revenue in the third quarter 2026 (Q3 2026), +8% from a year earlier. MedSurg and Neurotechnology: brought in $3.7B (56%); Orthopaedics: brought in $2.9B (44%). Of every dollar of revenue, 65¢ was left as gross profit, 16¢ was left as operating profit, 12¢ was left as net earnings.
What is Stryker's biggest business?
MedSurg and Neurotechnology:: $3.7B in the third quarter 2026, 56% of revenue, +9% from a year earlier.
What is Stryker's profit margin?
Net earnings were $753M, 11.5% of revenue, in the third quarter 2026; the operating margin was 15.9%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.